利钠肽家族中的 B 型利钠肽（BNP）和 N 末端 B 型利钠肽原（NT-proBNP）是目前在心衰诊疗中应用最广泛的生物标志物，有助于急慢性心衰的诊断和鉴别诊断、危险分层、疗效监测及预后评估。 同是心衰标志物，BNP 与 NT-proBNP 有什么联系和区别呢？ 01 BNP＆NT-proBNP ...

BNP是一种心脏分泌的肽类激素，其主要使命是调节体内的水盐平衡并抑制心脏的压力。然而，仅凭BNP水平的高低来判断一个人是否患有心衰，可能会导致错误的诊断。许多研究，包括2019年的《传感器》期刊，指出BNP水平的变化可以受多种因素的影响，如年龄、体重、肾功能等。因此，临床医生不能仅只依赖BNP数据，必须结合其他临床指标全面评估患者的心脏健康状况。

B-type natriuretic peptide (BNP) and its precursor, N-terminal pro-brain BNP (NT-proBNP) have been extensively studied for their predictive value in patients with heart failure. A systematic ...

Obesity influences the thresholds, but even in nonobese patients with dyspnea, optimal cutoffs may be lower than recommended.

Circulating concentrations of B-type natriuretic peptide (BNP) and the N-terminal fragment (NT) of its prohormone (proBNP) are related to cardiac function and have emerged as clinically useful ...

For patients in the natriuretic peptide arm, therapy was increased in a step-wise fashion according to a predetermined algorithm until NT-proBNP targets were met (<1,691 ng/l). At the end of the ...

The inactive N-terminal fragment of pro-brain natriuretic peptide (NT-proBNP) has been linked to ventricular dysfunction in the general population, and is predictive of cardiac events. Corteville ...

This has previously been speculated, as elevated concentrations of BNP or N-terminal pro brain natriuretic peptide (NT-proBNP) in cardiovascular patients were found to be related to immune reactions ...

A newer assay measuring NT-terminal pro-BNP (NT-proBNP) is more sensitive to detect heart failure and used in many institutions. The levels of BNP and NT-proBNP are essentially the same in normal ...

An assay measuring N-terminal pro-BNP, or NT-proBNP, is more sensitive to detect heart failure and used in many institutions. The levels of BNP and NT-proBNP are essentially the same in normal ...

Creative Diagnostics announced the launch of its new range of BNP and NT-proBNP antibodies for raw material and research applications. The natriuretic peptides, including proBNP (pro-brain ...

(MENAFN- EIN Presswire) Creative Diagnostics announced the launch of its new range of BNP and NT-proBNP antibodies for raw material and research applications. NEW YORK, NY, UNITED STATES ...